☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Leo Pharma
Leo Pharma to Acquire Timber for ~$36M
August 22, 2023
PharmaShots Weekly Snapshots (February 06 - 10, 2023)
February 10, 2023
LEO Pharma Reports P-III Trial (DELTA 2) Results of Delgocitinib for Chronic Hand Eczema
February 10, 2023
LEO Pharma’s Adtralza (tralokinumab) Receives the Health Canada’s Approval for the Treatment of Atopic Dermatitis
February 9, 2023
Insights+: EMA Marketing Authorization of New Drugs in October 2022
November 23, 2022
LEO Pharma Reports 32-Week Results from a Post-hoc Analysis of Adbry (tralokinumab-ldrm) in P-III (ECZTRA 3) Trial for Atopic Derm...
July 21, 2022
Load more...
Back to Home